News

  • DNV Capital Lin Yunfeng was invited to attend Zhaoqing Science and Innovation summit meeting

    2019
    06-11
  • 2019 traditional medicine international development BBS (Europe and Africa)

    2019
    05-31
  • DNV Capital won the title of 36Kr “the top 10 most powerful business growth venture capital institution in China”.

    2018
    11-30
  • China Alliance for Rare Disease Holds Inaugural Meeting

    2018
    11-09
  • Sorrento Therapeutics will Present at Roth Capital Partners 30th Annual Growth Stock Conference

    2018
    03-08
  • FiRe Convenes Selects TruTag as a 2017 Firestarter Company

    2017
    06-14
  • Kevin Lin Won the Best Global Cross-border Investors 2016

    2016
    11-25
  • NEEQ Approved The Investment Project of DNV Capital

    2016
    07-23
  • Kotler Medical Park - Grand Opening

    2016
    06-11
  • TruTag Technologies selected Edison Awards Finalist for 2014

    2015
    09-01
  • Dr. Hank Wuh, Chairman of TruTag., interviewed by Foxnews

    2015
    07-24
  • Kevin Lin was Awarded the Best Cross-border Investor on ChinaVenture-Hurun Midas List 2016

    2014
    04-15
  • WuXi PharmaTech Corporate Venture Fund Invests in TruTag

    2014
    04-03
  • The first TAVI in India

    2014
    03-04
  • The way forward in valvular disease interventional therapy

    2014
    02-26
  • DNV Capital sponsored CIC 2014

    2014
    01-14
  • Trutag was awarded as Health and Safety Product of 2013

    2013
    12-29
  • Kevin Lin attended Shan Xi Private Capital Forum

    2013
    09-27
  • Venus – P valve stent was used in China's first PPVI

    2013
    09-11
  • DNV Capital exits from Vessix Vascular

    2013
    07-29